Core Viewpoint - Zhejiang Xianju Pharmaceutical Co., Ltd. has decided to deregister its subsidiary, Xianju County Juhua Financial Services Co., Ltd., due to changes in financial policies and the cessation of its original business operations [1][18]. Group 1: Company Decision - The decision to deregister the subsidiary was approved during the 15th meeting of the 8th Board of Directors and the 10th meeting of the 8th Supervisory Board held on August 10, 2025 [1][24]. - The deregistration does not require approval from the shareholders' meeting as it falls within the decision-making authority of the Board of Directors [2][18]. Group 2: Subsidiary Information - Xianju County Juhua Financial Services Co., Ltd. was established in June 2016 with a registered capital of 50 million yuan, and the company held a 20% stake valued at 10 million yuan [1][2]. - The subsidiary's business primarily involved providing loan turnover services for small and medium-sized enterprises, which has now ceased [18]. Group 3: Financial Impact - The deregistration will not affect the company's business development or profitability, nor will it harm the interests of shareholders, especially minority shareholders [18][20]. - There have been no other related transactions with the controlling shareholder, Xianju County Industrial Investment Development Group Co., Ltd., since the beginning of the year [18]. Group 4: Independent and Supervisory Opinions - The independent directors have reviewed and approved the deregistration proposal, stating it aligns with the company's development needs and does not harm shareholder interests [18][20]. - The supervisory board also agrees with the decision, confirming that the process followed legal and regulatory requirements [20][25].
浙江仙琚制药股份有限公司关于注销参股公司暨关联交易的公告